Erlotero-150

Erlotero-150 is a prescription medicine containing Erlotinib 150 mg. It is an anticancer tablet mainly used for certain types of non-small cell lung cancer, depending on cancer type, mutation status, and the doctor’s treatment plan. Erlotinib may also be used in some cases of pancreatic cancer with another medicine such as gemcitabine, as advised by an oncologist. Tiny box, very serious oncology business.

Composition:

Erlotinib – 150 mg

Key Information:

Brand Name: Erlotero-150
Strength: 150 mg
Active Ingredient: Erlotinib
Dosage Form: Tablets
Medicine Type: Anticancer medicine / EGFR tyrosine kinase inhibitor
Manufacturer/Company: To be verified from physical label
Common Use: Treatment of certain non-small cell lung cancer cases
Other Prescribed Uses: Pancreatic cancer in selected cases, usually with gemcitabine, as prescribed
Administration: Oral use
Category: Prescription medicine
Pack Size: 30 tablets

How It Works:

Erlotero-150 works by blocking EGFR tyrosine kinase, a signal pathway that can help some cancer cells grow and multiply. By blocking this activity, erlotinib may help slow or control the growth of certain cancer cells when used as prescribed.

Potential Indications:

• Non-small cell lung cancer, also called NSCLC
• EGFR mutation-related lung cancer cases
• Advanced or metastatic lung cancer, as advised by an oncologist
• Pancreatic cancer in selected cases with combination therapy
• Other doctor-directed oncology use based on diagnosis and reports

Dosage & Storage:

Take only as directed by a qualified healthcare professional.
Follow the dosage instructions printed on the label or prescribed by the doctor.
For NSCLC, official prescribing information commonly lists 150 mg once daily on an empty stomach, at least 1 hour before or 2 hours after food, but the final dose and duration must be decided by the treating doctor.
Store in a cool, dry place away from direct sunlight and moisture.
Keep out of reach of children.

Important Safety Information:

Erlotinib should be used carefully under medical supervision, especially in patients with lung problems, liver issues, kidney problems, severe diarrhea, skin reactions, eye problems, or breathing-related symptoms.

Possible side effects may include:

• Skin rash
• Diarrhea
• Nausea
• Vomiting
• Loss of appetite
• Tiredness
• Dry skin
• Mouth irritation
• Eye irritation
• Liver-related problems
• Rare but serious lung inflammation or breathing difficulty

Serious symptoms such as severe diarrhea, worsening cough, shortness of breath, fever, yellowing of skin or eyes, severe rash, blistering skin, or eye pain should be reported to a doctor immediately.

Label Verification:

Please double-check the physical product label before listing or use, including the product name, strength, active ingredient, manufacturer details, batch number, expiry date, storage instructions, dosage directions, and packaging information.

General Information Disclaimer:

The information provided here is for general educational and product-identification purposes only. It should not be considered medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any medication regimen.